Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

583 Press Releases
DateTitleCompany
05 May 11 The European Commission Approves Pfizer’s Revatio® (sildenafil) for the Treatment of Pulmonary Arterial Hypertension in Children Pfizer Inc.,
Published by
Business Wire
03 May 11 PRISTIQ® (desvenlafaxine) Extended Release Tablets Shown To Significantly Reduce Number And Severity Of Moderate-To-Severe Hot Flashes Associated With Menopause Pfizer Inc.,
Published by
Business Wire
03 May 11 Pfizer Reports First-Quarter 2011 Results Pfizer Inc.,
Published by
Business Wire
02 May 11 Centrum® multivitamins and Celebrity Personal Trainer Harley Pasternak Share Star-Tested Secrets to Shape up for Summer Pfizer Inc.,
Published by
Business Wire
29 Apr 11 HealthMPowers Partners with Pfizer and Middle Georgia Medical Society to Launch “Empowering Healthy Choices”, a Multi-Year Health Promotion Pilot in Four Bibb County, Ga. Schools Pfizer Inc.,
Published by
Business Wire
28 Apr 11 Pfizer Hosts Annual Meeting of Shareholders Pfizer Inc.,
Published by
Business Wire
28 Apr 11 Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
27 Apr 11 Pfizer Launches New Advanced GOLD Range Of Early Child Nutrition Products Pfizer Inc.,
Published by
Business Wire
22 Apr 11 Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005 Pfizer Inc.,
Published by
Business Wire
21 Apr 11 Pfizer Invites Public To Listen To Webcast Of April 28 Annual Meeting Of Shareholders Pfizer Inc.,
Published by
Business Wire
20 Apr 11 Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership Pfizer Inc.,
Published by
Business Wire
15 Apr 11 Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
13 Apr 11 Tafamidis, An Oral, Investigational Compound For The Treatment Of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) Sustained A Slowing Of Disease Progression Over 30 Months Pfizer Inc.,
Published by
Business Wire
13 Apr 11 FDA Advisory Committee Finds Data Support The Favorable Benefit-Risk Profile Of SUTENT® In Unresectable Pancreatic Neuroendocrine Tumors (NET) Pfizer Inc.,
Published by
Business Wire
06 Apr 11 FIRST INJECTABLE TREATMENT INDICATED FOR DUPUYTREN'S CONTRACTURE, LAUNCHED IN UK Pfizer,
Published by
PharmiWeb.com
05 Apr 11 Pfizer Invites Public To View And Listen To Webcast Of May 3 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
05 Apr 11 Pfizer to Sell Capsugel to KKR Pfizer, KKR,
Published by
PharmiWeb.com
04 Apr 11 Pfizer to Sell Capsugel to KKR Pfizer,
Published by
Business Wire
04 Apr 11 Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application Pfizer Inc.,
Published by
Business Wire
01 Apr 11 Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010 Pfizer Inc.,
Published by
Business Wire
26 Mar 11 Greenstone Announces Voluntary Nationwide Recall of Citalopram and Finasteride Due to Possible Mislabeling Pfizer Inc.,
Published by
Business Wire
25 Mar 11 Pfizer Animal Health Continues to Invest in the Future of Veterinarians with Announcement of 2011 Veterinary Scholarship Recipients Pfizer Inc.,
Published by
Business Wire
24 Mar 11 SPIRIVA HandiHaler Prolonged Time To First COPD Exacerbation, New Study In NEJM Shows Pfizer,
Published by
Business Wire
04 Mar 11 Pfizer Announces Primary Endpoints Met In Second Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
01 Mar 11 King Pharmaceuticals, Inc. Announces Final Results of Its Offer to Purchase Convertible Notes Pfizer Inc.,
Published by
Business Wire
01 Mar 11 Pfizer Completes Acquisition Of King Pharmaceuticals, Inc. Pfizer Inc.,
Published by
Business Wire
01 Mar 11 Pfizer Announces Updated, Interactive Development Pipeline Pfizer Inc.,
Published by
Business Wire
01 Mar 11 XIAPEX® (Collagenase Clostridium Histolyticum) Authorized in the European Union (EU) For Dupuytren’s Contracture Pfizer,
Published by
Business Wire
23 Feb 11 NH Citizens Health Initiative to Premiere Mini-Documentaries on NH Multi-Stakeholder Patient Centered Medical Home Pilot Pfizer Inc.,
Published by
Business Wire
23 Feb 11 U.S. Supreme Court Decision In Bruesewitz V. Wyeth A Win For Public Health Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.